Teva Pharmaceutical Industries Ltd ADR buy Truist Financial Co.
Start price
29.01.26
/
50%
€27.00
Target price
29.01.27
€31.75
Performance (%)
0.00%
Price
14.04.26
€27.00
Summary
This prediction is currently active. The BUY prediction by Truist_Financial_Co_ is currently unchanged from the start price. This prediction currently runs until 29.01.27. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Teva Pharmaceutical Industries Ltd ADR | 6.719% | 6.719% |
| iShares Core DAX® | 4,24 % | 2,86 % |
| iShares Nasdaq 100 | 4,89 % | 2,81 % |
| iShares Nikkei 225® | 9,40 % | 7,83 % |
| iShares S&P 500 | 3,53 % | 1,95 % |
Comments by Truist_Financial_Co_ for this prediction
In the thread Teva Pharmaceutical Industries Ltd ADR diskutieren
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at Truist Financial Corporation from $36.00 to $38.00. They now have a "buy" rating on the stock.
Ratings data for TEVA provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Teva Pharmaceutical Industries Ltd ADR
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€28.90
18.02.26
18.02.26
€35.46
18.02.27
18.02.27
-6.57%
14.04.26
14.04.26
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€15.95
28.05.25
28.05.25
€22.09
28.05.26
28.05.26
69.28%
14.04.26
14.04.26